112 related articles for article (PubMed ID: 14687906)
1. Complex formation between human kallikrein 13 and serum protease inhibitors.
Kapadia C; Yousef GM; Mellati AA; Magklara A; Wasney GA; Diamandis EP
Clin Chim Acta; 2004 Jan; 339(1-2):157-67. PubMed ID: 14687906
[TBL] [Abstract][Full Text] [Related]
2. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids.
Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP
Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 13 involvement in extracellular matrix degradation.
Kapadia C; Ghosh MC; Grass L; Diamandis EP
Biochem Biophys Res Commun; 2004 Oct; 323(3):1084-90. PubMed ID: 15381110
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay.
Kapadia C; Chang A; Sotiropoulou G; Yousef GM; Grass L; Soosaipillai A; Xing X; Howarth DH; Diamandis EP
Clin Chem; 2003 Jan; 49(1):77-86. PubMed ID: 12507963
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Scorilas A; Borgoño CA; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
J Clin Oncol; 2004 Feb; 22(4):678-85. PubMed ID: 14966091
[TBL] [Abstract][Full Text] [Related]
6. Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
Oikonomopoulou K; Batruch I; Smith CR; Soosaipillai A; Diamandis EP; Hollenberg MD
Biol Chem; 2010 Apr; 391(4):381-90. PubMed ID: 20180649
[TBL] [Abstract][Full Text] [Related]
7. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
8. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
9. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin.
Hutchinson S; Luo LY; Yousef GM; Soosaipillai A; Diamandis EP
Clin Chem; 2003 May; 49(5):746-51. PubMed ID: 12709365
[TBL] [Abstract][Full Text] [Related]
10. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
[TBL] [Abstract][Full Text] [Related]
11. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.
Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP
Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772
[TBL] [Abstract][Full Text] [Related]
12. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
[TBL] [Abstract][Full Text] [Related]
13. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
Luo LY; Jiang W
Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
[TBL] [Abstract][Full Text] [Related]
14. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
15. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
16. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
Michael IP; Sotiropoulou G; Pampalakis G; Magklara A; Ghosh M; Wasney G; Diamandis EP
J Biol Chem; 2005 Apr; 280(15):14628-35. PubMed ID: 15713679
[TBL] [Abstract][Full Text] [Related]
18. Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.
Hanke S; Tindall CA; Pippel J; Ulbricht D; Pirotte B; Reboud-Ravaux M; Heiker JT; Sträter N
J Med Chem; 2020 Jun; 63(11):5723-5733. PubMed ID: 32374603
[TBL] [Abstract][Full Text] [Related]
19. Anterior pituitary glandular kallikrein: trypsin activation and estrogen regulation.
Powers CA
Mol Cell Endocrinol; 1986 Jul; 46(2):163-74. PubMed ID: 3522314
[TBL] [Abstract][Full Text] [Related]
20. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
Schapira M; Scott CF; Colman RW
J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
